Supadopa TR 195 mg is an extended-release capsule formulated to manage the symptoms of Parkinson’s disease and related disorders. It combines Levodopa, a precursor to dopamine that replenishes diminished dopamine levels in the brain, with Carbidopa, which inhibits the peripheral breakdown of Levodopa, ensuring more reaches the brain and reducing side effects like nausea. The extended-release formulation allows for sustained symptom control with fewer daily doses.